Identification of variations in blood-brain barrier opening after cerebral ischemia by dual contrast-enhanced magnetic resonance imaging and T1sat measurements

Stroke

Volumn 39, Issue 2, 2008, Pages 427-432

  Nagaraja, Tavarekere N ^a   Karki, Kishor ^a,b   Ewing, James R ^a,b   Croxen, Richard L ^a   Knight, Robert A ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Brain drug delivery; Brain imaging; Middle cerebral artery; Neurovascular unit

Indexed keywords

BOVINE SERUM ALBUMIN; CONTRAST MEDIUM; DEXTRAN; EVANS BLUE; COLORING AGENT; DIAGNOSTIC AGENT; GADOLINIUM BOVINE SERUM ALBUMIN COMPLEX; GADOLINIUM PENTETATE; GADOLINIUM-BOVINE SERUM ALBUMIN COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTRAST ENHANCEMENT; FLUORESCENCE MICROSCOPY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY; RAT; REPERFUSION; STATISTICAL SIGNIFICANCE; WISTAR RAT; ANIMAL; BRAIN CIRCULATION; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STROKE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; COLORING AGENTS; CONTRAST MEDIA; EVANS BLUE; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; STROKE;

EID: 39349087419     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.496059     Document Type: Article

References (34)

1. Yang GY, Betz AL. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke. 1994;25:1658-1664; discussion, 1664-1665.
2. Aronowski J, Labiche LA. Perspectives on reperfusion-induced damage in rodent models of experimental focal ischemia and role of γ-protein kinase C. Ilar J. 2003;44:105-109.
3. Aronowski J, Strong R, Grotta JC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab. 1997;17:1048-1056.
4. Huang ZG, Xue D, Preston E, Karbalai H, Buchan AM. Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci. 1999;26:298-304.
5. Lo EH, Singhal AB, Torchilin VP, Abbott NJ. Drug delivery to damaged brain. Brain Res Rev. 2001;38:140-148.
6. Jiang Q, Zhang RL, Zhang ZG, Knight RA, Ewing JR, Ding G, Lu M, Arniego P, Zhang L, Hu J, Li Q, Chopp M. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat. J Cereb Blood Flow Metab. 2002;22:559-568.
7. Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke. 2004;35:2220-2225.
8. Lo EH, Moskowitz MA, Jacobs TP. Exciting, radical, suicidal: how brain cells die after stroke. Stroke. 2005;36:189-192.
9. Nagaraja TN, Keenan KA, Brown SL, Fenstermacher JD, Knight RA. Relative distribution of plasma flow markers and red blood cells across BBB openings in acute cerebral ischemia. Neurol Res. 2007;29:78-80.
10. 3H]inulin across rat blood-brain barrier after cerebral ischemia. Acta Neuropathol. 2002;103:237-242.
11. Knight RA, Barker PB, Fagan SC, Li Y, Jacobs MA, Welch KM. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke. 1998;29:144-151.
12. Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004;35(suppl 1):2659-2661.
13. Yenari M, Beaulieu C, Iwai K, Seri S, Steinberg G, Moseley ME Characterization of hemorrhagic embolic infarction using diffusion-weighted imaging. Fourth Scientific Meeting of the International Society for Magnetic Resonance in Medicine. 1996:487. Abstract.
14. Ewing JR, Jiang Q, Boska M, Zhang L, Zhang ZG, Brown SL, Li GH, Divine GW, Chopp M. T1 and magnetization transfer at 7 Tesla in acute ischemic infarct in the rat. Magn Reson Med. 1999;41:696-705.
15. Knight RA, Nagesh V, Nagaraja TN, Ewing JR, Whitton PA, Bershad E, Fagan SC, Fenstermacher JD. Acute BBB opening in experimentally induced focal cerebral ischemia is preferentially identified by quantitative magnetization transfer imaging. Magn Reson Med. 2005;54:822-832.
16. Fagan SC, Nagaraja TN, Fenstermacher JD, Zheng J, Johnson M, Knight RA. Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a non-embolic stroke model. Neurol Res. 2003;25:377-382.
17. Strich G, Hagan PL, Gerber KH, Slutsky RA. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA. Radiology. 1985;154:723-726.
18. Nagaraja TN, Croxen RL, Panda S, Knight RA, Keenan KA, Brown SL, Fenstermacher JD, Ewing JR. Application of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agent. J Neurosci Methods. 2006;157:238-245.
19. Knight RA, Nagaraja TN, Ewing JR, Nagesh V, Whitton PA, Bershad E, Fagan SC, Fenstermacher JD. Quantitation and localization of blood-to-brain influx by MRI and quantitative autoradiography in a model of transient focal ischemia. Magn Reson Med. 2005;54:813-821.
20. 14C-sucrose in areas of blood-brain opening. Magn Reson Med. 2003;50:283-292.
21. Ewing JR, Wei L, Knight RA, Pawa S, Nagaraja TN, Brusca T, Divine GW, Fenstermacher JD. Direct comparison of local cerebral blood flow rates measured by MRI arterial spin-tagging and quantitative autoradiography in a rat model of experimental cerebral ischemia. J Cereb Blood Flow Metab. 2003;23:198-209.
22. Brix G, Schad LR, Deimling M, Lorenz WJ. Fast and precise T1 imaging using a TOMROP sequence. Magn Reson Imaging. 1990;8:351-356.
23. Nagaraja TN, Nagesh V, Ewing JR, Whitton PA, Fenstermacher JD, Knight RA. Step-down infusions of Gd-DTPA yield greater contrast-enhanced magnetic resonance images of BBB damage in acute stroke than bolus injections. Magn Reson Imaging. 2007;25:311-318.
24. Ding G, Nagesh V, Jiang Q, Zhang L, Zhang ZG, Li L, Knight RA, Li Q, Ewing JR, Chopp M. Early prediction of gross hemorrhagic transformation by noncontrast agent MRI cluster analysis after embolic stroke in rat. Stroke. 2005;36:1247-1252.
25. Preston E, Foster DO. Evidence for pore-like opening of the blood-brain barrier following forebrain ischemia in rats. Brain Res. 1997;761:4-10.
26. Mayhan WG, Heistad DD. Permeability of blood-brain barrier to various sized molecules. Am J Physiol Heart Circ Physiol. 1985;248:H712-H718.
27. Nicholson C, Sykova E. Extracellular space structure revealed by diffusion analysis. Trends Neurosci. 1998;21:207-215.
28. Murakami K, Kawase M, Kondo T, Chan PH. Cellular accumulation of extravasated serum protein and DNA fragmentation following vasogenic edema. J Neurotrauma. 1998;15:825-835.
29. Liu KF, Li F, Tatlisumak T, Garcia JH, Sotak CH, Fisher M, Fenstermacher JD. Regional variations in the apparent diffusion coefficient and the intra-cellular distribution of water in rat brain during acute focal ischemia. Stroke. 2001;32:1897-1905.
30. Rosenberg GS, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brains. Stroke. 1998;29:2189-2195.
31. Habgood MD, Bye N, Dziegielewska KM, Ek CJ, Lane MA, Potter A, Morganti-Kossman C, Saunders NR. Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice. Eur J Neurosci. 2007;25:231-238.
32. Lo EH, Pan Y, Matsumoto K, Kowall NW. Blood-brain barrier disruption in experimental focal ischemia: comparison between in vivo MRI and immunocytochemistry. Magn Reson Imaging. 1994;12:403-411.
33. Jiang Q, Ewing JR, Ding GL, Zhang L, Zhang ZG, Li L, Whitton P, Lu M, Hu J, Li QJ, Knight RA, Chopp M. Quantitative evaluation of BBB permeability after embolic stroke in rat using MRI. J Cereb Blood Flow Metab. 2005;25:583-592.
34. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab. 2004;24:945-963.